Section of Neurology, Department of Internal Medicine, Rafael Méndez Hospital, Murcia Health Service, 30813 Lorca, Murcia, Spain.
Murcia Biomedical Research Institute (IMIB-Arrixaca), 30120 Murcia, Spain.
Nutrients. 2021 Feb 22;13(2):700. doi: 10.3390/nu13020700.
The Mediterranean diet (MD) has shown to reduce the occurrence of several chronic diseases. To evaluate its potential protective role on dementia incidence we studied 16,160 healthy participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain Dementia Cohort study recruited between 1992-1996 and followed up for a mean (±SD) of 21.6 (±3.4) years. A total of 459 incident cases of dementia were ascertained through expert revision of medical records. Data on habitual diet was collected through a validated diet history method to assess adherence to the relative Mediterranean Diet (rMED) score. Hazard ratios (HR) of dementia by rMED levels (low, medium and high adherence levels: ≤6, 7-10 and ≥11 points, respectively) were estimated using multivariable Cox models, whereas time-dependent effects were evaluated using flexible parametric Royston-Parmar (RP) models. Results of the fully adjusted model showed that high versus low adherence to the categorical rMED score was associated with a 20% (HR = 0.80, 95%CI: 0.60-1.06) lower risk of dementia overall and HR of dementia was 8% (HR = 0.92, 0.85-0.99, = 0.021) lower for each 2-point increment of the continuous rMED score. By sub-types, a favorable association was also found in women for non-AD (HR per 2-points = 0.74, 95%CI: 0.62-0.89), while not statistically significant in men for AD (HR per 2-points = 0.88, 0.76-1.01). The association was stronger in participants with lower education. In conclusion, in this large prospective cohort study MD was inversely associated with dementia incidence after accounting for major cardiovascular risk factors. The results differed by dementia sub-type, sex, and education but there was no significant evidence of effect modification.
地中海饮食(MD)已被证明可以降低几种慢性疾病的发生。为了评估其对痴呆发病率的潜在保护作用,我们研究了 16160 名来自欧洲癌症与营养前瞻性调查(EPIC)-西班牙痴呆队列研究的健康参与者,该研究于 1992 年至 1996 年期间招募,并随访了平均(±SD)21.6(±3.4)年。通过对医疗记录的专家审查确定了 459 例痴呆的新发病例。通过经过验证的饮食历史方法收集了习惯性饮食的数据,以评估相对地中海饮食(rMED)评分的依从性。使用多变量 Cox 模型估计了 rMED 水平(低、中、高依从水平:分别为≤6、7-10 和≥11 分)的痴呆风险比(HR),而使用灵活参数 Royston-Parmar(RP)模型评估了时间依赖性效应。完全调整后的模型结果表明,与低水平相比,高水平的 rMED 评分与痴呆的整体风险降低 20%(HR=0.80,95%CI:0.60-1.06)相关,而 rMED 评分每增加 2 分,痴呆的 HR 降低 8%(HR=0.92,0.85-0.99,=0.021)。按亚型划分,女性的非 AD(每增加 2 分 HR=0.74,95%CI:0.62-0.89)和男性的 AD(每增加 2 分 HR=0.88,0.76-1.01)也存在有利的相关性。在受教育程度较低的参与者中,相关性更强。总之,在这项大型前瞻性队列研究中,在地中海饮食与痴呆发病率之间存在负相关,这是在考虑到主要心血管危险因素之后得出的。结果因痴呆亚型、性别和教育程度而异,但没有明显的效应修饰证据。